这是一篇来自已证抗体库的有关人类 TGFBR2的综述,是根据31篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合TGFBR2 抗体。
TGFBR2 同义词: AAT3; FAA3; LDS1B; LDS2; LDS2B; MFS2; RIIC; TAAD2; TBR-ii; TBRII; TGFR-2; TGFbeta-RII

艾博抗(上海)贸易有限公司
小鼠 单克隆(MM0056-4F14)
  • 免疫细胞化学; 人类; 图 6
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab78419)被用于被用于免疫细胞化学在人类样本上 (图 6). Cancers (Basel) (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2000; 图 5c
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab186838)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5c). Int J Oncol (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 图 2c
  • 免疫印迹; 人类; 图 2e, 5a
  • 免疫印迹; 小鼠; 图 4h
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab61213)被用于被用于免疫组化在人类样本上 (图 2c), 被用于免疫印迹在人类样本上 (图 2e, 5a) 和 被用于免疫印迹在小鼠样本上 (图 4h). Clin Transl Med (2021) ncbi
domestic rabbit 多克隆
  • 免疫沉淀; 人类; 1:100; 图 5f
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab225902)被用于被用于免疫沉淀在人类样本上浓度为1:100 (图 5f). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit 单克隆(EPR14673)
  • 免疫印迹; 小鼠; 1:1000; 图 6b
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab184948)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6b). Aging (Albany NY) (2021) ncbi
小鼠 单克隆(MM0056-4F14)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2b
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab78419)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2b). Pflugers Arch (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 图 4a
  • 免疫印迹; 人类; 图 4c
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab186838)被用于被用于免疫组化在人类样本上 (图 4a) 和 被用于免疫印迹在人类样本上 (图 4c). Front Oncol (2020) ncbi
domestic rabbit 多克隆
  • 其他; 小鼠; 1:200; 图 2c
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, Ab61213)被用于被用于其他在小鼠样本上浓度为1:200 (图 2c). Sci Rep (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5c
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab186838)被用于被用于免疫印迹在小鼠样本上 (图 5c). Proc Natl Acad Sci U S A (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 6c
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab61213)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 6c). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1a, 1d
  • 免疫印迹; 人类; 1:1000; 图 2b
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab61213)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1a, 1d) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2b). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 2c
艾博抗(上海)贸易有限公司 TGFBR2抗体(abcam, ab61213)被用于被用于免疫组化在小鼠样本上 (图 2c). Circulation (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 5
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab61213)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5). PLoS ONE (2016) ncbi
小鼠 单克隆(MM0056-4F14)
  • 流式细胞仪; 人类; 1:20; 图 s10
艾博抗(上海)贸易有限公司 TGFBR2抗体(Abcam, ab78419)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 s10). Nat Commun (2015) ncbi
小鼠 单克隆(MM0056-4F14)
  • 免疫组化; 人类; 图 1
艾博抗(上海)贸易有限公司 TGFBR2抗体(abcam, ab78419)被用于被用于免疫组化在人类样本上 (图 1). Mol Cancer (2015) ncbi
圣克鲁斯生物技术
小鼠 单克隆(C-4)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 7a
圣克鲁斯生物技术 TGFBR2抗体(Santa Cruz, sc-17791)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 7a). Mol Med Rep (2022) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹基因敲除验证; 人类; 1:1000; 图 5e
圣克鲁斯生物技术 TGFBR2抗体(Santa Cruz, sc-17799)被用于被用于免疫印迹基因敲除验证在人类样本上浓度为1:1000 (图 5e). Nat Commun (2021) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 1:1000; 图 5a
  • 免疫印迹; 小鼠; 1:300; 图 5a, 5c
圣克鲁斯生物技术 TGFBR2抗体(Santa Cruz, sc-17799)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a) 和 被用于免疫印迹在小鼠样本上浓度为1:300 (图 5a, 5c). J Biol Chem (2021) ncbi
小鼠 单克隆(E-6)
  • 免疫印迹; 人类; 1:500; 图 4
圣克鲁斯生物技术 TGFBR2抗体(Santa Cruz, 17792)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4). Nat Commun (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 TGFBR2抗体(Santa Cruz, sc-17799)被用于被用于免疫印迹在人类样本上浓度为1:500. PLoS ONE (2015) ncbi
小鼠 单克隆(E-6)
  • 免疫印迹; 人类; 图 s2
圣克鲁斯生物技术 TGFBR2抗体(Santa Cruz, sc-17792)被用于被用于免疫印迹在人类样本上 (图 s2). Sci Rep (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 s3
圣克鲁斯生物技术 TGFBR2抗体(santa Cruz, sc-17799)被用于被用于免疫印迹在人类样本上 (图 s3). Oncotarget (2015) ncbi
小鼠 单克隆(C-4)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 TGFBR2抗体(Santa Cruz, Sc-17791)被用于被用于免疫印迹在人类样本上 (图 3). Sci Rep (2015) ncbi
小鼠 单克隆(E-6)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 TGFBR2抗体(Santa Cruz Biotechnology, sc-17792)被用于被用于免疫印迹在人类样本上 (图 2). FASEB J (2014) ncbi
安迪生物R&D
domestic goat 多克隆
  • 抑制或激活实验; 小鼠; 图 4d
安迪生物R&D TGFBR2抗体(R&D System, AF-241-NA)被用于被用于抑制或激活实验在小鼠样本上 (图 4d). Signal Transduct Target Ther (2021) ncbi
domestic goat 多克隆
  • 免疫组化; 小鼠; 1:100; 图 1a
安迪生物R&D TGFBR2抗体(R&D, AF-241)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 1a). elife (2019) ncbi
北京傲锐东源
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6a
北京傲锐东源 TGFBR2抗体(OriGene, TA311643)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6a). J Clin Invest (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6a
北京傲锐东源 TGFBR2抗体(OriGene, TA311643)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6a). Nat Commun (2020) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 6j
赛默飞世尔 TGFBR2抗体(Invitrogen, PA5-36115)被用于被用于免疫印迹在小鼠样本上 (图 6j). Sci Adv (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 5c
赛默飞世尔 TGFBR2抗体(Thermal scientific, PA5-37755)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5c). Front Pharmacol (2020) ncbi
西格玛奥德里奇
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2500; 图 4a
西格玛奥德里奇 TGFBR2抗体(Sigma-Aldrich, SAB4504269)被用于被用于免疫印迹在人类样本上浓度为1:2500 (图 4a). Mol Med Rep (2018) ncbi
文章列表
  1. Yeh C, Liu H, Lee M, Leu Y, Chiang W, Chang H, et al. Phytochemical‑rich herbal formula ATG‑125 protects against sucrose‑induced gastrocnemius muscle atrophy by rescuing Akt signaling and improving mitochondrial dysfunction in young adult mice. Mol Med Rep. 2022;25: pubmed 出版商
  2. Nakamura I, Asumda F, Moser C, Kang Y, Lai J, Roberts L. Sulfatase-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway. Cancers (Basel). 2021;13: pubmed 出版商
  3. Zhang M, Pan X, Fujiwara K, Jurcak N, Muth S, Zhou J, et al. Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism. Signal Transduct Target Ther. 2021;6:366 pubmed 出版商
  4. Xi Y, Li Y, Xu P, Li S, Liu Z, Tung H, et al. The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1. Sci Adv. 2021;7:eabg9241 pubmed 出版商
  5. Huang J, Xiao R, Wang X, Khadka B, Fang Z, Yu M, et al. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2. Int J Oncol. 2021;59: pubmed 出版商
  6. Gu P, Wang D, Zhang J, Wang X, Chen Z, Gu L, et al. Protective function of interleukin-22 in pulmonary fibrosis. Clin Transl Med. 2021;11:e509 pubmed 出版商
  7. Bruce J, To K, Lui V, Chung G, Chan Y, Tsang C, et al. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape. Nat Commun. 2021;12:4193 pubmed 出版商
  8. Sun X, He Z, Guo L, Wang C, Lin C, Ye L, et al. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer. J Exp Clin Cancer Res. 2021;40:149 pubmed 出版商
  9. Shen K, Li R, Zhang X, Qu G, Li R, Wang Y, et al. Acetyl oxygen benzoate engeletin ester promotes KLF4 degradation leading to the attenuation of pulmonary fibrosis via inhibiting TGFβ1-smad/p38MAPK-lnc865/lnc556-miR-29b-2-5p-STAT3 signal pathway. Aging (Albany NY). 2021;13:13807-13821 pubmed 出版商
  10. Pan Y, Iejima D, Nakayama M, Suga A, Noda T, Kaur I, et al. Binding of Gtf2i-β/δ transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro. J Biol Chem. 2021;296:100456 pubmed 出版商
  11. Chen Y, Jhao P, Hung C, Wu Y, Lin S, Chiang W, et al. Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts. J Clin Invest. 2021;131: pubmed 出版商
  12. Schilpp C, Lochbaum R, Braubach P, Jonigk D, Frick M, Dietl P, et al. TGF-β1 increases permeability of ciliated airway epithelia via redistribution of claudin 3 from tight junction into cell nuclei. Pflugers Arch. 2021;473:287-311 pubmed 出版商
  13. Lee T, Yeh C, Lee Y, Shih Y, Chen Y, Hung C, et al. Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFβ signaling through TGFBR1 stabilization. Nat Commun. 2020;11:4254 pubmed 出版商
  14. Yang L, Han B, Zhang M, Wang Y, Tao K, Zhu M, et al. Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGFβ1/SMAD3 and JAK/STAT3 Profibrotic Signaling Pathways. Front Pharmacol. 2020;11:165 pubmed 出版商
  15. Fu X, Qie J, Fu Q, Chen J, Jin Y, Ding Z. miR-20a-5p/TGFBR2 Axis Affects Pro-inflammatory Macrophages and Aggravates Liver Fibrosis. Front Oncol. 2020;10:107 pubmed 出版商
  16. Voisin A, Damon Soubeyrand C, Bravard S, Saez F, Drevet J, Guiton R. Differential expression and localisation of TGF-β isoforms and receptors in the murine epididymis. Sci Rep. 2020;10:995 pubmed 出版商
  17. Wang W, Chun H, Baek J, Sadik J, Shirazyan A, Razavi P, et al. The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage. Proc Natl Acad Sci U S A. 2019;116:15570-15579 pubmed 出版商
  18. Ma W, Silverman S, Zhao L, Villasmil R, Campos M, Amaral J, et al. Absence of TGFβ signaling in retinal microglia induces retinal degeneration and exacerbates choroidal neovascularization. elife. 2019;8: pubmed 出版商
  19. Li T, Zhao J. Knockdown of elF3a inhibits TGF??1?induced extracellular matrix protein expression in keloid fibroblasts. Mol Med Rep. 2018;17:4057-4061 pubmed 出版商
  20. Koyama Y, Wang P, Liang S, Iwaisako K, Liu X, Xu J, et al. Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. J Clin Invest. 2017;127:1254-1270 pubmed 出版商
  21. Yang H, Zhang H, Zhong Y, Wang Q, Yang L, Kang H, et al. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer. Sci Rep. 2017;7:41670 pubmed 出版商
  22. Zangi L, Oliveira M, Ye L, Ma Q, Sultana N, Hadas Y, et al. Insulin-Like Growth Factor 1 Receptor-Dependent Pathway Drives Epicardial Adipose Tissue Formation After Myocardial Injury. Circulation. 2017;135:59-72 pubmed 出版商
  23. Cammareri P, Rose A, Vincent D, Wang J, Nagano A, Libertini S, et al. Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma. Nat Commun. 2016;7:12493 pubmed 出版商
  24. Bianchi E, Boekelheide K, Sigman M, Lamb D, Hall S, Hwang K. Ghrelin Inhibits Post-Operative Adhesions via Blockage of the TGF-β Signaling Pathway. PLoS ONE. 2016;11:e0153968 pubmed 出版商
  25. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed 出版商
  26. Bauer J, Ozden O, Akagi N, Carroll T, Principe D, Staudacher J, et al. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Mol Cancer. 2015;14:182 pubmed 出版商
  27. Lee J, Fricke F, Warnken U, Schnölzer M, Kopitz J, Gebert J. Reconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells. PLoS ONE. 2015;10:e0131506 pubmed 出版商
  28. Rojas Fernandez A, Herhaus L, MacArtney T, Lachaud C, Hay R, Sapkota G. Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9. Sci Rep. 2015;5:9811 pubmed 出版商
  29. Uppal A, Wightman S, Mallon S, Oshima G, Pitroda S, Zhang Q, et al. 14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015;6:3540-52 pubmed
  30. Rao R, Dhele N, Cheemadan S, Ketkar A, Jayandharan G, Palakodeti D, et al. Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming. Sci Rep. 2015;5:8229 pubmed 出版商
  31. Holtzhausen A, Golzio C, How T, Lee Y, Schiemann W, Katsanis N, et al. Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development. FASEB J. 2014;28:1248-67 pubmed 出版商